MRI Contrast Agents for Pharmacological Research

MRI Contrast Agents for Pharmacological Research

Bibliographic Details
Main Authors:	Enzo eTerreno, Silvio eAime
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-12-01
Series:	Frontiers in Pharmacology
Subjects:	Molecular Imaging Pharmacology MRI contrast agents theranostics
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00290/full

Similar Items

Targeted Contrast Agents for Molecular MRI
by: Sara Lacerda
Published: (2018-12-01)

Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery
by: Vera ePaefgen, et al.
Published: (2015-09-01)

MRI Contrast Agents in Glycobiology
by: Carlos F. G. C. Geraldes, et al.
Published: (2022-11-01)

Contrast Enhancement in MRI Using Combined Double Action Contrast Agents and Image Post-Processing in the Breast Cancer Model
by: David MacDonald, et al.
Published: (2023-04-01)

Ferritin: A Platform for MRI Contrast Agents Delivery
by: Maria Rosaria Ruggiero, et al.
Published: (2019-03-01)

Hybrid nano‐ and microgels doped with photoacoustic contrast agents for cancer theranostics
by: Yu Xiao, et al.
Published: (2021-12-01)

Nanomaterials incorporated ultrasound contrast agents for cancer theranostics
by: Lei Fu, et al.
Published: (2016-09-01)

Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents
by: Kim Hyo Jeong, et al.
Published: (2010-01-01)

Sonosensitive MRI Nanosystems as Cancer Theranostics: A Recent Update
by: Francesca Garello, et al.
Published: (2018-05-01)

A Manganese Porphyrin Platform for the Design and Synthesis of Molecular and Targeted MRI Contrast Agents
by: Kyle D. W. Vollett, et al.
Published: (2023-05-01)

Functionalized Nanomaterials as Tailored Theranostic Agents in Brain Imaging
by: Ramar Thangam, et al.
Published: (2021-12-01)

Update on the Use of PET/MRI Contrast Agents and Tracers in Brain Oncology: A Systematic Review
by: Smeraldo A, et al.
Published: (2022-07-01)

Multiwalled carbon nanotube hybrids as MRI contrast agents
by: Nikodem Kuźnik, et al.
Published: (2016-07-01)

Use of Manganese Supplement as an Alternative to Oral Contrast Agents for Gastrointestinal Tract Magnetic Resonance Imaging
by: zainab mankhi, et al.
Published: (2024-02-01)

How Could Nanomedicine Improve the Safety of Contrast Agents for MRI during Pregnancy?
by: Marinella Difonzo, et al.
Published: (2022-03-01)

Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy
by: Cai X, et al.
Published: (2019-10-01)

Nanosized <i>T</i><sub>1</sub> MRI Contrast Agent Based on a Polyamidoamine as Multidentate Gd Ligand
by: Paolo Arosio, et al.
Published: (2021-12-01)

A Photocleavable Contrast Agent for Light-Responsive MRI
by: Friederike Reeßing, et al.
Published: (2020-10-01)

The Challenge of T1 Contrast Agents for High-Magnetic Field MRI
by: Lothar Helm
Published: (2011-09-01)

Carbon Nano-Allotrope/Magnetic Nanoparticle Hybrid Nanomaterials as T2 Contrast Agents for Magnetic Resonance Imaging Applications
by: Yunxiang Gao
Published: (2018-02-01)

Bi-Magnetic Core-Shell CoFe<sub>2</sub>O<sub>4</sub>@MnFe<sub>2</sub>O<sub>4</sub> Nanoparticles for In Vivo Theranostics
by: Valentin Nica, et al.
Published: (2020-05-01)

A versatile genetic-encoded reporter for magnetic resonance imaging
by: Haiyang Yang, et al.
Published: (2023-03-01)

Functionalization of Magnetic Nanoparticles by Folate as Potential MRI Contrast Agent for Breast Cancer Diagnostics
by: Hamid Heydari Sheikh Hossein, et al.
Published: (2020-09-01)

Peptide-Based Soft Hydrogels Modified with Gadolinium Complexes as MRI Contrast Agents
by: Enrico Gallo, et al.
Published: (2020-01-01)

Spatially Localized Sono-Photoacoustic Activation of Phase-Change Contrast Agents
by: David S. Li, et al.
Published: (2020-12-01)

LDL mediated delivery of Paclitaxel and MRI imaging probes for personalized medicine applications
by: Sahar Rakhshan, et al.
Published: (2021-07-01)

New MRI contrast agents based on silicon nanotubes loaded with superparamagnetic iron oxide nanoparticles
by: Roberto Gonzalez-Rodriguez, et al.
Published: (2018-01-01)

Hard-Shelled Glycol Chitosan Nanoparticles for Dual MRI/US Detection of Drug Delivery/Release: A Proof-of-Concept Study
by: Simona Baroni, et al.
Published: (2023-08-01)

Multifunctional Fe<sub>3</sub>O<sub>4</sub>-Au Nanoparticles for the MRI Diagnosis and Potential Treatment of Liver Cancer
by: Elena Kozenkova, et al.
Published: (2020-08-01)

Effect of Europium Substitution on the Structural, Magnetic and Relaxivity Properties of Mn-Zn Ferrite Nanoparticles: A Dual-Mode MRI Contrast-Agent Candidate
by: Hamidreza Saeidi, et al.
Published: (2023-01-01)

L-EGCG-Mn nanoparticles as a pH-sensitive MRI contrast agent
by: Jiali Li, et al.
Published: (2021-01-01)

Liver-targeting MRI contrast agent based on galactose functionalized o-carboxymethyl chitosan
by: Li Xu, et al.
Published: (2023-05-01)

Quantitative monitoring of paramagnetic contrast agents and their allocation in plant tissues via DCE-MRI
by: Simon Mayer, et al.
Published: (2022-04-01)

Molecular Resonance Imaging of the CAIX Expression in Mouse Mammary Adenocarcinoma Cells
by: Claudia Quattrociocchi, et al.
Published: (2023-09-01)

Development of a Dual Drug-Loaded, Surfactant-Stabilized Contrast Agent Containing Oxygen
by: Raj Patel, et al.
Published: (2022-04-01)

Estrogen receptor targeted contrast agents for molecular magnetic resonance imaging of breast cancer hormonal status
by: Adi ePais, et al.
Published: (2016-04-01)

pH-responsive theranostic nanocomposites as synergistically enhancing positive and negative magnetic resonance imaging contrast agents
by: Xi Huang, et al.
Published: (2018-03-01)

Radical Dendrimers Based on Biocompatible Oligoethylene Glycol Dendrimers as Contrast Agents for MRI
by: Songbai Zhang, et al.
Published: (2020-08-01)

Repurposing Clinical Agents for Chemical Exchange Saturation Transfer Magnetic Resonance Imaging: Current Status and Future Perspectives
by: Zelong Chen, et al.
Published: (2020-12-01)

Study on Establishing Reference Safe Concentrations of MRI Contrast Agents for Optimized Images: Paramagnetic Gd-DTPA-BMEA and Superparamagnetic Ferucarbotran
by: Wen-Tien Hsiao, et al.
Published: (2021-01-01)